This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT03283826
Brief Title: Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis (EMBOLD)

First Submitted : September 13, 2017
First Submitted that Met QC Criteria : September 13, 2017
First Posted : September 14, 2017

Last Update Submitted that Met QC Criteria : April 24, 2023
Last Update Posted : April 25, 2023